TRIB
Trinity Biotech plc
NASDAQ: TRIB · HEALTHCARE · MEDICAL DEVICES
$0.60
+0.00% today
Updated 2026-04-30
Market cap
$12.18M
P/E ratio
—
P/S ratio
0.25x
EPS (TTM)
$-1.60
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
WallStSmart proprietary scores
27
out of 100
Grade: F
Strong Sell
Investment rating
2.0
Growth
F5.0
Quality
C+2.0
Profitability
F7.0
Valuation
B+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$3.00
+400.00%
12-Month target
—
—
Intrinsic (DCF)
$5.52
Margin of safety
+85.09%
Price chart
X-Ray snapshot
Strengths
+ 85.09% below intrinsic value
Risks
- Thin margins at -75.90%
- Negative free cash flow $-77109.00
- Revenue declining -5.50% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $81.15M | $62.52M | $56.83M | $61.55M | $48.57M |
| Net income | $875000.00 | $-41.00M | $-24.02M | $-31.79M | $-5.11M |
| EPS | — | — | — | — | $-1.60 |
| Free cash flow | $4.55M | $-6.90M | $-12.36M | $-14.26M | $-77109.00 |
| Profit margin | 1.08% | -65.58% | -42.26% | -51.64% | -75.90% |
Peer comparison
Smart narrative
Trinity Biotech plc trades at $0.60. Our Smart Value Score of 27/100 indicates the stock is weak. TTM revenue stands at $48.57M. with profit margins at -75.90%. Our DCF model estimates intrinsic value at $5.52.
Frequently asked questions
What is Trinity Biotech plc's stock price?
Trinity Biotech plc (TRIB) trades at $0.60.
Is Trinity Biotech plc overvalued?
Smart Value Score 27/100 (Grade F, Strong Sell). DCF value $5.52.
What is the price target of Trinity Biotech plc (TRIB)?
The analyst target price is $3.00, representing +400.0% upside from the current price of $0.60.
What is the intrinsic value of Trinity Biotech plc (TRIB)?
Based on our DCF model, intrinsic value is $5.52, a +85.1% margin of safety versus $0.60.
What is Trinity Biotech plc's revenue?
TTM revenue is $48.57M.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.25x
ROE-1,913.00%
Beta0.79
50D MA$0.68
200D MA$0.91
Shares out0.02B
Float0.29B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—